CY2027 Home Health Final Rule Tightens Provider Enrollment, Updates DMEPOS Policies

On November 9, CMS published the CY2027 Home Health Prospective Payment System final rule (CMS-1844-F). Beyond home health payment updates, the rule finalizes significant changes to Medicare provider enrollment requirements, along with several DMEPOS-specific policies.

Unless otherwise noted, the changes take effect January 1, 2027.

Key provisions include:

• Expansion of CMS Provider Enrollment Policies: Makes nearly all revocation reasons retroactive, with effective dates tied to the underlying event; s allows reapplication bars of up to 10 years for any denial reason; and new authority to revoke “high-risk” enrollments.
• Clarification Effective Date of Moratoriums: Clarifies that temporary moratoriums effective date will be effective on the date the moratorium notice was filed with the Office of Federal Register, making the effective date immediate, before the notice is published on the Federal Register.
• DMEPOS Replacement Clarification: For items on the Required Face-to-Face (F2F) Encounter and Written Orders Prior to Delivery List, replacement items will not require a new F2F encounter if the items fall within the same HCPCS code. However, a new F2F encounter is required if the replacement item has a different HCPCS code.
• DME Definition Expansion to Include External Infusion Pumps and Drugs: Effective April 1, 2027, DME definition will expand to include certain external infusion pumps and associated home infusion drugs. To qualify for coverage, the drug must be infused at least 12 times per year and require a health care professional to be physically on-site at home to administer or supervise the administration.

You can find AAHomecare’s full summary here.